Skip to content

Cannabis: all studies

Page 184 of 289: studies 1,831 to 1,840 of 2,882, newest first. Back to the cannabis overview

Research

Electroencephalographic and behavioral alterations produced by delta-1-tetrahydrocannabinol.

Science May 28, 1971 C H Hockman, R G Perrin, H Kalant

The administration of small doses of Delta(l)-tetrahydrocannabinol to cats with indwelling electrodes produced a disruption of both the electroencephalogram and behavior. Some of these alterations, including the appearance of a high-voltage slow wave electroencephalogram in the awake and moving animal, have been observed in cats that had been administered other drugs known to cause...

The Electroencephalogram in Cannabis Associated Psychosis

Canadian Psychiatric Association Journal April 1, 1971 D. R. Campbell

Comparison was made among the electroencephalograms of eleven patients with psychotic reactions after the use of cannabis, twenty-nine patients admitted with a diagnosis of schizophrenia, ten for neurological consultations and eleven cannabis users with no apparent psychiatric implications. It was found that there was a greater increase in the EEG abnormalities of cannabis users than in the...

Comparison of tetrahydrocannabinol and synhexyl in man

Clinical Pharmacology & Therapeutics November 1, 1968 Leo E. Hollister, R. K. Richards, H. K. Gillespie 195 citations

A synthetic isomer of tetrahydrocannabinol (1‐Δ'‐3,4‐transtetrahydrocannabinol), believed to be identical to the most active naturally occurring THC, was compared with a semisynthetic THC‐like compound, synhexyl. Sixteen volunteer subiects received THC in doses ranging from 341 to 946 p.g per kilo gram (median 581). Thirteen subjects received synhexyl in doses ranging from 633 to 2,666 µg per...

A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses

Journal of Mental Science October 1, 1958 Frances R. Ames 184 citations

This paper describes an inquiry into the effects of giving oral doses of the narcotic drug variously known as hashish, marihuana and, in South Africa, dagga. The drug is a preparation from the plant Cannabis sativa whose narcotic effect has been known for centuries. The writer's interest in it was inspired by the work in recent years on the mental disturbances produced by the active principles...

Evaluating Delta-8-THC-Induced Psychosis: A Systematic Review.

Clinical Neuropharmacology Megan Jayne Ralston, Alim Osman 1 citation

This study reviews literature on the psychiatric effects of delta-8-THC, particularly psychosis and severe mental health outcomes, to highlight the need for further research and regulation. Marijuana, the most widely used illicit drug in the United States, sees increasing use due to legalization. Although moderate use is generally safe, adverse effects can occur, especially in those with...

Persistent Amotivation After Cannabis‐Related Psychosis: Diagnostic Challenges and Clinical Course With Electroconvulsive Therapy: A Case Report

Neuropsychopharmacology Reports December 1, 2026 Yukina Kitano, Ryohei Takada, Minobu Ikehara et al.

ABSTRACT: Background: Cannabis use may cause psychotic symptoms, such as hallucinations and delusions, as well as persistent amotivation with reduced motivation, inactivity, and cognitive impairment. Although described as cannabis‐related amotivational syndrome, it is not recognized as an independent diagnostic entity and overlaps clinically with the negative symptoms of schizophrenia and mood...

Longitudinal fMRI reveals altered developmental trajectories of functional network organisation associated with adolescent cannabis use

Elizabeth J Davies, Natalie Ertl, Tom P. Freeman et al.

Adolescence is a critical period of brain development during which the endocannabinoid system continues to mature. These developmental changes may contribute to age-related differences in the association between cannabis use and large-scale functional network organisation, yet this association remains incompletely characterised. We hypothesised that regular cannabis use would be associated with...

Indeterminacy of Cannabis Impairment and ∆9-Tetrahydrocannabinol (∆9-THC) Levels in Blood and Breath

Michael W. DeGregorio, Gregory T. Wurz preprint

Abstract: Previous investigators have found no clear relationship between specific blood concentrations of D9-tetrahydrocannabinol (D9-THC) and impairment, and thus no scientific justification for use of legal “per se” D9-THC blood concentration limits. Analyzing blood from 30 subjects showed D9-THC concentrations that exceeded 5 ng/mL in 16 of the 30 subjects following a 12-hour period of...

The genetic basis of the human-cannabis relationship

Philippe Henry preprint

Abstract: Cannabis can elicit various reactions in different consumers. In order to shed light on the mechanisms underlying the human-cannabis relationship, we begin to investigate the genetic basis of this differential response. The web-based platform OpenSNP was used to collect selfreported genetic and phenotypic data. Participants either reported a positively or negative affinity to...

Online Knowledge Translation Program Involving Video Games and University Student–Led Tutorials About Cannabis and Psychosis for Black Youth: Mixed Method Feasibility Study (Preprint)

Payal Jani, Nuri Song, Erin Artna et al.

BACKGROUND We have piloted a new online knowledge translation (KT) program created to educate youth about cannabis effects, which uniquely focuses on mental health risks for Black youth. Youth are generally unaware of the research linking underage usage and the risk of psychosis. Youth from some Black racialized communities in Ontario may be disproportionately affected and in need of this...